Wolfe Research Has Lowered Expectations for CVS Health (NYSE:CVS) Stock Price

CVS Health (NYSE:CVS) had its price objective dropped by equities researchers at Wolfe Research from $100.00 to $97.00 in a research note issued on Monday,MarketScreener reports. The firm currently has an “outperform” rating on the pharmacy operator’s stock. Wolfe Research’s target price points to a potential upside of 20.63% from the stock’s previous close.

A number of other brokerages have also commented on CVS. Bank of America decreased their price objective on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a report on Tuesday, January 27th. Truist Financial set a $100.00 price target on shares of CVS Health in a research note on Wednesday, December 10th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Finally, Argus cut their price target on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. Nineteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $94.77.

CVS Health Stock Down 1.5%

CVS opened at $80.41 on Monday. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The stock’s fifty day simple moving average is $78.50 and its 200 day simple moving average is $77.47. CVS Health has a 1-year low of $58.35 and a 1-year high of $85.15. The stock has a market cap of $102.30 billion, a PE ratio of 58.27, a price-to-earnings-growth ratio of 0.85 and a beta of 0.49.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. The company had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company’s revenue was up 8.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, research analysts expect that CVS Health will post 5.89 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Harbor Capital Advisors Inc. lifted its holdings in shares of CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the period. Caitong International Asset Management Co. Ltd grew its position in shares of CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 281 shares during the last quarter. Swiss RE Ltd. acquired a new stake in shares of CVS Health in the fourth quarter valued at about $26,000. Sankala Group LLC acquired a new position in shares of CVS Health in the fourth quarter worth approximately $28,000. Finally, Mcguire Capital Advisors Inc. acquired a new stake in CVS Health during the 4th quarter valued at approximately $28,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.